✦ LIBER ✦

NF-Y is necessary for hematopoietic stem cell proliferation and survival

✍ Scribed by Bungartz, G.; Land, H.; Scadden, D. T.; Emerson, S. G.

Book ID: 118030596
Publisher: American Society of Hematology
Year: 2012
Tongue: English
Weight: 592 KB
Volume: 119
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2011-06-359406

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TET2 is essential for survival and hemat

TET2 is essential for survival and hematopoietic stem cell homeostasis

✍ Shide, K; Kameda, T; Shimoda, H; Yamaji, T; Abe, H; Kamiunten, A; Sekine, M; Hid 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 580 KB

Pleiotrophin Signaling Is Necessary for

Pleiotrophin Signaling Is Necessary for Hematopoietic Stem Cell Self Renewal and Is Regulated by the Bone Marrow Microenvironment

✍ H.A. Himburg; P. Daher; L. Russell; P. Doan; M. Quarmyne; S. Meadows; G. Herrado 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Cul4A is required for hematopoietic stem

Cul4A is required for hematopoietic stem-cell engraftment and self-renewal

✍ Li, B.; Jia, N.; Waning, D. L.; Yang, F.-C.; Haneline, L. S.; Chun, K. T. 📂 Article 📅 2007 🏛 American Society of Hematology 🌐 English ⚖ 289 KB

Stem cell factor is a chemoattractant an

Stem cell factor is a chemoattractant and a survival factor for CNS stem cells

✍ Anna Erlandsson; Jimmy Larsson; Karin Forsberg-Nilsson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Predictors of prolonged survival after a

Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

✍ Qaiser Bashir; Hassan Khan; Robert Z. Orlowski; Ali Imran Amjad; Nina Shah; Simr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 746 KB

## Abstract A total of 149 patients with multiple myeloma (MM) who received allogeneic hematopoietic stem cell transplantation (allo‐HCT) with myeloablative (MAC; __n__ = 38) or reduced‐intensity conditioning (RIC; __n__ = 110) regimens at MD Anderson Cancer Center were evaluated. Of the total, 120

Survival after autologous hematopoietic

Survival after autologous hematopoietic stem cell transplantation for patients with inflammatory breast carcinoma

✍ Banu Arun; Rebecca Slack; Edmund Gehan; Thomas Spitzer; Kenneth R. Meehan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

## BACKGROUND. The authors retrospectively determined the clinical outcome of patients with inflammatory breast carcinoma (IBC) treated with high dose chemotherapy (HDC) and autologous bone marrow (ABM) or peripheral blood stem cell (PBSC) support. ## METHODS. Twenty-four consecutive patients w